白癜风表现为皮肤上的色素斑和斑块，并且可以显着影响患者的生活质量。尽管有几种治疗方式，在个体和疾病亚型之间,色素沉着的发生率差异很大.对于药物治疗效果不佳的稳定型白癜风患者，黑素细胞-角质形成细胞移植程序（MKTP）是可行的选择。虽然这种自体非培养细胞移植程序的变化是由世界各地的皮肤科外科医生进行的，并显示出良好的耐受性和有效性，它在美国仍未得到充分利用。我们对MKTP进行了全面的概述，强调循证和实用技术，以提高患者的治疗效果。作为一种宝贵的资源，这项审查旨在支持寻求将MKTP纳入其实践并提高对其益处的认识的皮肤科外科医生，最终培养更全面的白癜风护理方法。
Vitiligo manifests as depigmented macules and patches on the skin and can significantly impact a patient\'s quality of life. Despite the availability of several treatment modalities, rates of repigmentation can vary widely among individuals and disease subtypes. For patients with stable vitiligo who have not achieved satisfactory results with medical treatments, the melanocyte-keratinocyte transplantation procedure (MKTP) is a viable option. While variations of this autologous non-cultured cellular grafting procedure are performed by dermatologic surgeons worldwide and has shown good tolerability and effectiveness, it remains under utilized in the United States. We present a comprehensive overview of MKTP, highlighting evidence-based and practical techniques to enhance patient outcomes. By serving as a valuable resource, this review aims to support dermatologic surgeons seeking to incorporate MKTP into their practice and promote awareness regarding its benefits, ultimately fostering a more comprehensive approach to vitiligo care.
